268 related articles for article (PubMed ID: 18221162)
1. An insight on targets and patented drugs for chemotherapy of Chagas disease.
Duschak VG; Couto AS
Recent Pat Antiinfect Drug Discov; 2007 Jan; 2(1):19-51. PubMed ID: 18221162
[TBL] [Abstract][Full Text] [Related]
2. A decade of targets and patented drugs for chemotherapy of Chagas disease.
Duschak VG
Recent Pat Antiinfect Drug Discov; 2011 Sep; 6(3):216-59. PubMed ID: 21824073
[TBL] [Abstract][Full Text] [Related]
3. Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period.
Duschak VG
Recent Pat Antiinfect Drug Discov; 2016; 11(2):74-173. PubMed ID: 27784230
[TBL] [Abstract][Full Text] [Related]
4. Clear Shot at Primary Aim: Susceptibility of Trypanosoma cruzi Organelles, Structures and Molecular Targets to Drug Treatment.
Menna-Barreto RF; de Castro SL
Curr Top Med Chem; 2017; 17(10):1212-1234. PubMed ID: 27784255
[TBL] [Abstract][Full Text] [Related]
5. Trypanothione Reductase: A Target for the Development of Anti- Trypanosoma cruzi Drugs.
Vázquez K; Paulino M; Salas CO; Zarate-Ramos JJ; Vera B; Rivera G
Mini Rev Med Chem; 2017; 17(11):939-946. PubMed ID: 28302040
[TBL] [Abstract][Full Text] [Related]
6. Chagas Disease and Coumarins: A Review of Natural and Synthetic Coumarins As Anti-Trypanosoma Cruzi Agents.
Gonçalves GA; Cerecetto H; Poser GLV; Canto RFS; Eifler-Lima VL
Mini Rev Med Chem; 2021; 21(13):1701-1717. PubMed ID: 33372872
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of Chagas' disease: status and new developments.
Cerecetto H; González M
Curr Top Med Chem; 2002 Nov; 2(11):1187-213. PubMed ID: 12171581
[TBL] [Abstract][Full Text] [Related]
8. Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host.
Maya JD; Cassels BK; Iturriaga-Vásquez P; Ferreira J; Faúndez M; Galanti N; Ferreira A; Morello A
Comp Biochem Physiol A Mol Integr Physiol; 2007 Apr; 146(4):601-20. PubMed ID: 16626984
[TBL] [Abstract][Full Text] [Related]
9. Major Kinds of Drug Targets in Chagas Disease or American Trypanosomiasis.
Duschak VG
Curr Drug Targets; 2019; 20(11):1203-1216. PubMed ID: 31020939
[TBL] [Abstract][Full Text] [Related]
10. Trypanosoma cruzi targets for new chemotherapeutic approaches.
Soeiro MN; de Castro SL
Expert Opin Ther Targets; 2009 Jan; 13(1):105-21. PubMed ID: 19063710
[TBL] [Abstract][Full Text] [Related]
11. [The chemotherapy of Chagas disease].
Stoppani AO
Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of Chagas disease.
Urbina JA
Curr Pharm Des; 2002; 8(4):287-95. PubMed ID: 11860367
[TBL] [Abstract][Full Text] [Related]
13. Advances in Chagas disease drug development: 2009-2010.
Buckner FS; Navabi N
Curr Opin Infect Dis; 2010 Dec; 23(6):609-16. PubMed ID: 20885320
[TBL] [Abstract][Full Text] [Related]
14. Polypharmacology in the Treatment of Chagas Disease.
Aguilera E; Alvarez G; Cerecetto H; González M
Curr Med Chem; 2019; 26(23):4476-4489. PubMed ID: 29637852
[TBL] [Abstract][Full Text] [Related]
15. Anti-T. cruzi agents: our experience in the evaluation of more than five hundred compounds.
Cerecetto H; González M
Mini Rev Med Chem; 2008 Nov; 8(13):1355-83. PubMed ID: 18991753
[TBL] [Abstract][Full Text] [Related]
16. Current advances in drug discovery for Chagas disease.
Scarim CB; Jornada DH; Chelucci RC; de Almeida L; Dos Santos JL; Chung MC
Eur J Med Chem; 2018 Jul; 155():824-838. PubMed ID: 30033393
[TBL] [Abstract][Full Text] [Related]
17. Chagas disease: progress and new perspectives.
Sánchez-Sancho F; Campillo NE; Páez JA
Curr Med Chem; 2010; 17(5):423-52. PubMed ID: 20015038
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Biological in vitro and in vivo Evaluation of 2-(5-Nitroindazol-1-yl)ethylamines and Related Compounds as Potential Therapeutic Alternatives for Chagas Disease.
Martín-Escolano R; Aguilera-Venegas B; Marín C; Martín-Montes Á; Martín-Escolano J; Medina-Carmona E; Arán VJ; Sánchez-Moreno M
ChemMedChem; 2018 Oct; 13(19):2104-2118. PubMed ID: 30098232
[TBL] [Abstract][Full Text] [Related]
19. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.
Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559
[TBL] [Abstract][Full Text] [Related]
20. Natural and synthetic naphthoquinones active against Trypanosoma cruzi: an initial step towards new drugs for Chagas disease.
Salas CO; Faúndez M; Morello A; Maya JD; Tapia RA
Curr Med Chem; 2011; 18(1):144-61. PubMed ID: 21110810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
